Anomalous diffusion model has been introduced and shown to be beneficial in clinical applications, compared with conventional diffusion models. However, the anisotropy of anomalous diffusion was neglected and its clinical feasibility remains uncertain. In this study, the use of anisotropy of anomalous diffusion is investigated for differentiating low- and high-grade cerebral gliomas. Based on the results, it is shown that the anisotropy of anomalous diffusion offers advantages compared to that of conventional diffusion models, indicating its potential to facilitate future studies of neuropathological changes in clinical populations.
This abstract and the presentation materials are available to members only; a login is required.